Full access to all news articles, including in-depth analysis and opinion pieces.
Exclusive interviews with experts and influential figures.
Enhanced multimedia experience with videos, photo galleries, and interactive graphics.
Ad-free browsing for a seamless reading experience.
Global Insights
$
$
9.99
$
0
/ 30 days
/ 30 days
placeholder text
Global Insights Subscription:
All features of the Premium Subscription.
Exclusive access to monthly webinars or live Q&A sessions with our journalists and correspondents, providing insights into the news-gathering process and global events.
Customizable news alerts tailored to your specific interests and regions.
Early access to special investigative reports and in-depth features.
An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023.Brendan McDermid | ReutersMedicare drug plans can now cover Eli...
Andrew Witty, CEO of UnitedHealth Group, testifies during the Senate Finance Committee hearing titled "Hacking America's Health Care: Assessing the Change Healthcare Cyber Attack and What's Next," in the...
Cows are seen standing in a feedlot on June 14, 2023 in Quemado, Texas.Brandon Bell | Getty ImagesU.S. health officials are monitoring and preparing to combat bird flu in...
A person rides past a Walgreens truck, owned by the Walgreens Boots Alliance, Inc., in Manhattan, New York City, U.S., November 26, 2021. Andrew Kelly | ReutersWalgreens on Thursday reported...
A pharmacist displays boxes of Ozempic, a semaglutide injection drug used for treating type 2 diabetes made by Novo Nordisk, at Rock Canyon Pharmacy in Provo, Utah, U.S. March...
Shares of Walgreens closed 5% lower on Thursday after the company reported fiscal first-quarter adjusted earnings and revenue that topped expectations, but cut its quarterly dividend nearly in half. The...